Last reviewed · How we verify
NCT05994560
The Value of Uterine Artery Occlusion in Laparoscopic Myomectomy
NA trial testing With temporary occlusion in Uterine Myomectomy in 80 participants. Completed in 21 December 2022.
21 December 2022
Quick facts
| Lead sponsor | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 2 March 2020 |
| Primary completion | 21 December 2022 |
| Estimated completion | 21 December 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- With temporary occlusion
Conditions studied
- Uterine Myomectomy — all drugs for Uterine Myomectomy →
Sponsor
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Who can join
Adults 18 to 50, female only, with Uterine Myomectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to determine whether patients undergoing laparoscopic myomectomy with temporary occlusion of the uterine arteries and utero-ovarian ligaments using clips experience a decrease in blood loss during surgery compared to patients who undergo laparoscopic myomectomy without clips.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Surgical impact of bilateral transient occlusion of uterine and utero-ovarian arteries during laparoscopic myomectomy.
Moratalla-Bartolomé E, Lázaro-de-la-Fuente J, López-Carrasco I, Cabezas-López E, et al · · 2024 · cited 5× · PMID 38528094 · DOI 10.1038/s41598-024-57720-9
Verify or expand the search:
- PubMed search for NCT05994560
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal trials
Trials by the same sponsor.
- NCT07490964 — Polycystic Ovary Syndrome in Type 1 Diabetes · not yet recruiting
- NCT07440186 — Exploratory Clinical Research for the Evaluation of Human GMP (Good Manufacturing Practice) Collagen Implants (Humabiolo · NA · not yet recruiting
- NCT07484009 — ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure · NA · recruiting
- NCT07034976 — Efficacy of Non-ablative Radiofrequency Combined With Pelvic Floor Muscle Training for Genitourinary Syndrome of Menopau · NA · recruiting
- NCT06338072 — Impact of the Menstrual Cycle in Reproductive Aged Women With Type 1 Diabetes Using a Closed Loop System (DIABETEXX/1). · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05994560 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
- Last refreshed: 16 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05994560.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing